Literature DB >> 28866337

The possibility of adverse effect of Kv7-channel opener retigabine on memory processes in rats.

Ewa Zwierzyńska1, Agata Krupa-Burtnik2, Bogusława Pietrzak2.   

Abstract

OBJECTIVE: Retigabine is a novel antiepileptic drug with a unique and complex mechanism of action which allows its use in many diseases associated with impaired neuronal activity. This study sought to examine the impact of retigabine on two types of memory in rats.
METHODS: Adult male Wistar rats were used to assess the effect of retigabine, administered p.o. as single (10mg/kg or 20mg/kg) or repeated doses, on spatial memory with the Morris water maze test (MWM) and emotional memory, associated with fear, with the passive avoidance test (PA).
RESULTS: Retigabine administered at a high single dose transiently impairs learning processes in rats. In the MWM, these changes were delayed in time and of a lesser degree when retigabine was given at low single dose. Additionally, the drug administered repeatedly for 2weeks slowed learning processes in the MWM, but this effect occurred only after 1week of administration in the PA.
CONCLUSION: These findings indicate that retigabine may affect memory and learning processes, especially in the first phase of administration.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28866337     DOI: 10.1016/j.yebeh.2017.08.004

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  2 in total

1.  Beneficial effect of retigabine on memory in rats receiving ethanol.

Authors:  Ewa Zwierzyńska; Agata Krupa-Burtnik; Bogusława Pietrzak
Journal:  Pharmacol Rep       Date:  2020-12-31       Impact factor: 3.024

2.  Molecular Insights Into Binding and Activation of the Human KCNQ2 Channel by Retigabine.

Authors:  Barbara Garofalo; Alexandre M J J Bonvin; Andrea Bosin; Francesco P Di Giorgio; Rosella Ombrato; Attilio V Vargiu
Journal:  Front Mol Biosci       Date:  2022-03-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.